Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucio Miele

Showing results (191-200 of 217) with videos related to

Pageof 22
Sort By:
Plos One|October 9, 2020
Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumorTiffany C Chang, Margarite D Matossian, Steven Elliott, et al.
Plos One|April 29, 2021
Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumorTiffany C Chang, Margarite D Matossian, Steven Elliott, et al.
Journal of Cellular Physiology|June 3, 2015
p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1Jieun Yun, Ingrid Espinoza, Antonio Pannuti, et al.
Nature Medicine|May 9, 2006
Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic strokeThiruma V Arumugam, Sic L Chan, Dong-Gyu Jo, et al.
Frontiers in Immunology|October 30, 2023
Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancerFokhrul Hossain, Deniz A Ucar, Giulia Monticone, et al.
Women'S Health Reports (New Rochelle, N.Y.)|March 31, 2021
Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast CancerMargarite D Matossian, Alexandra A Giardina, Maryl K Wright, et al.
Nature Immunology|July 2, 2005
Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21Lisa M Minter, Danielle M Turley, Pritam Das, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|July 2, 2024
Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variantsA Jerrod Anzalone, William H Beasley, Kimberly Murray, et al.
Plos One|May 7, 2014
Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cellsMaria De Salvo, Lavinia Raimondi, Serena Vella, et al.
BMC Cancer|March 9, 2019
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft modelMargarite D Matossian, Hope E Burks, Steven Elliott, et al.
Pageof 22

Showing results (191-200 of 217) with videos related to

Sort By:
Pageof 22
Plos One|October 9, 2020
Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumorTiffany C Chang, Margarite D Matossian, Steven Elliott, et al.
Plos One|April 29, 2021
Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumorTiffany C Chang, Margarite D Matossian, Steven Elliott, et al.
Journal of Cellular Physiology|June 3, 2015
p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1Jieun Yun, Ingrid Espinoza, Antonio Pannuti, et al.
Nature Medicine|May 9, 2006
Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic strokeThiruma V Arumugam, Sic L Chan, Dong-Gyu Jo, et al.
Frontiers in Immunology|October 30, 2023
Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancerFokhrul Hossain, Deniz A Ucar, Giulia Monticone, et al.
Women'S Health Reports (New Rochelle, N.Y.)|March 31, 2021
Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast CancerMargarite D Matossian, Alexandra A Giardina, Maryl K Wright, et al.
Nature Immunology|July 2, 2005
Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21Lisa M Minter, Danielle M Turley, Pritam Das, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|July 2, 2024
Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variantsA Jerrod Anzalone, William H Beasley, Kimberly Murray, et al.
Plos One|May 7, 2014
Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cellsMaria De Salvo, Lavinia Raimondi, Serena Vella, et al.
BMC Cancer|March 9, 2019
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft modelMargarite D Matossian, Hope E Burks, Steven Elliott, et al.
Pageof 22